Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?

Line Lundegaard Bang; Lone Wulff Madsen; Rune Micha Pedersen; Anna Christine Nilsson; Isik Somuncu Johansen; Thomas Emil Andersen

doi:10.1016/j.jiph.2024.102512

Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?

Line Lundegaard Bang^*, Lone Wulff Madsen, Rune Micha Pedersen, Anna Christine Nilsson, Isik Somuncu Johansen, Thomas Emil Andersen

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › Research › peer-review

9 Downloads (Pure)

Original language	English
Article number	102512
Journal	Journal of Infection and Public Health
Volume	17
Issue number	9
ISSN	1876-0341
DOIs	https://doi.org/10.1016/j.jiph.2024.102512
Publication status	Published - Sept 2024

Documents & Links

10.1016/j.jiph.2024.102512Licence: CC BY

Open Access VersionFinal published version, 869 KBLicence: CC BY

Cite this

Bang, L. L., Madsen, L. W., Pedersen, R. M., Nilsson, A. C., Johansen, I. S., & Andersen, T. E. (2024). Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early? Journal of Infection and Public Health, 17(9), Article 102512. https://doi.org/10.1016/j.jiph.2024.102512

@article{31727958609a4d76acb10d755f41ede3,

title = "Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?",

author = "Bang, {Line Lundegaard} and Madsen, {Lone Wulff} and Pedersen, {Rune Micha} and Nilsson, {Anna Christine} and Johansen, {Isik Somuncu} and Andersen, {Thomas Emil}",

year = "2024",

month = sep,

doi = "10.1016/j.jiph.2024.102512",

language = "English",

volume = "17",

journal = "Journal of Infection and Public Health",

issn = "1876-0341",

publisher = "Elsevier",

number = "9",

}

Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early? / Bang, Line Lundegaard ; Madsen, Lone Wulff ; Pedersen, Rune Micha et al.
In: Journal of Infection and Public Health, Vol. 17, No. 9, 102512, 09.2024.

Research output: Contribution to journal › Comment/debate › Research › peer-review

TY - JOUR

T1 - Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective

T2 - Were monoclonal antibodies against COVID-19 rejected too early?

AU - Bang, Line Lundegaard

AU - Madsen, Lone Wulff

AU - Pedersen, Rune Micha

AU - Nilsson, Anna Christine

AU - Johansen, Isik Somuncu

AU - Andersen, Thomas Emil

PY - 2024/9

Y1 - 2024/9

U2 - 10.1016/j.jiph.2024.102512

DO - 10.1016/j.jiph.2024.102512

M3 - Comment/debate

C2 - 39137507

SN - 1876-0341

VL - 17

JO - Journal of Infection and Public Health

JF - Journal of Infection and Public Health

IS - 9

M1 - 102512

ER -